Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Wasungu

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Molecules (Basel, Switzerland)|December 6, 2016
Drug Release by Direct Jump from Poly(ethylene-glycol-b-ε-caprolactone) Nano-Vector to Cell MembraneUgo Till, Laure Gibot, Anne-Françoise Mingotaud, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 27, 2016
Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trialBernard Chevalier, Yoshinobu Onuma, Ad J van Boven, et al.
Biophysical Reviews|May 17, 2017
Gene electrotransfer: from biophysical mechanisms to in vivo applications : Part 1- Biophysical mechanismsJean-Michel Escoffre, Chloé Mauroy, Thomas Portet, et al.
The Journal of Gene Medicine|June 8, 2010
Cationic and anionic lipoplexes inhibit gene transfection by electroporation in vivoNathalie Mignet, Gaëlle Vandermeulen, Gaëlle Pembouong, et al.
Journal of the American College of Cardiology|February 20, 2016
A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: 5-Year Follow-UpPatrick W Serruys, John Ormiston, Robert-Jan van Geuns, et al.
Lancet (London, England)|September 19, 2014
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trialPatrick W Serruys, Bernard Chevalier, Dariusz Dudek, et al.
JACC. Cardiovascular Interventions|July 25, 2015
Incidence and Potential Mechanism(s) of Post-Procedural Rise of Cardiac Biomarker in Patients With Coronary Artery Narrowing After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold or Everolimus-Eluting Metallic StentYuki Ishibashi, Takashi Muramatsu, Shimpei Nakatani, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Molecules (Basel, Switzerland)|December 6, 2016
Drug Release by Direct Jump from Poly(ethylene-glycol-b-ε-caprolactone) Nano-Vector to Cell MembraneUgo Till, Laure Gibot, Anne-Françoise Mingotaud, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 27, 2016
Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trialBernard Chevalier, Yoshinobu Onuma, Ad J van Boven, et al.
Biophysical Reviews|May 17, 2017
Gene electrotransfer: from biophysical mechanisms to in vivo applications : Part 1- Biophysical mechanismsJean-Michel Escoffre, Chloé Mauroy, Thomas Portet, et al.
The Journal of Gene Medicine|June 8, 2010
Cationic and anionic lipoplexes inhibit gene transfection by electroporation in vivoNathalie Mignet, Gaëlle Vandermeulen, Gaëlle Pembouong, et al.
Journal of the American College of Cardiology|February 20, 2016
A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: 5-Year Follow-UpPatrick W Serruys, John Ormiston, Robert-Jan van Geuns, et al.
Lancet (London, England)|September 19, 2014
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trialPatrick W Serruys, Bernard Chevalier, Dariusz Dudek, et al.
JACC. Cardiovascular Interventions|July 25, 2015
Incidence and Potential Mechanism(s) of Post-Procedural Rise of Cardiac Biomarker in Patients With Coronary Artery Narrowing After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold or Everolimus-Eluting Metallic StentYuki Ishibashi, Takashi Muramatsu, Shimpei Nakatani, et al.
Pageof 2